Bosch Healthcare, a German company has unveiled the new, fully automated rapid test-kit for COVID-19 that can help medical facilities such as doctors’ offices, hospitals, laboratories, and health centers make fast diagnoses.
Bosch’s rapid COVID-19 test is the result of collaboration between the company’s Bosch Healthcare Solutions subsidiary and the Northern Irish medical technology company Randox Laboratories Ltd. The rapid molecular diagnostic test runs on the Vivalytic analysis device from Bosch Healthcare Solutions. “We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up the identification and isolation of infected patients,” says Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH.
Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours — measured from the time the sample is taken to the time the result arrives.
Another advantage of the rapid test is that it can be performed directly at the point of care. This eliminates the need to transport samples, which takes up valuable time.
It also means patients quickly gain certainty about their state of health, while allowing infected individuals to be identified and isolated immediately. With the tests currently in use, patients must usually wait one to two days for a result.
“Time is of the essence in the fight against coronavirus. Reliable, rapid diagnosis directly on site with no back and forth — that is the great advantage of our solution, which we see as another example of technology that is ‘Invented for life,’” Denner says.
